Joshua S. Prince

Joshua S. Prince appears in our data through filings on VistaGen Therapeutics, Inc. shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 28 June 2024 to 31 December 2025.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 5 January 2026 with a share grant (€2,101) in VistaGen Therapeutics, Inc. Typically, a trade is published a median of 5 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.